ClinicalTrials.gg
RecruitingNCT07135765MRISCOLUpdated Aug 22, 2025

Paravertebral Muscles Assessment Using High-resolution MRI in Idiopathic or Neuromuscular Scoliosis Children

An interventional study of Additional 5 minutes of lying down position during MRI in Scoliosis, Scoliosis Idiopathic and Scoliosis Neuromuscular, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 10 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-08-22.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Non-randomized
Ages
10 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 57 studies in Scoliosis with a site in France — 18 open to participants now, 20 under way, 1 of them phase 3. Scoliosis · France.

Planned enrollment
24th of 25
10 · median 60
Started
2025
with 4 others
No phase
24 of 57
11 open now
Primary completion
2027-08
later than 6 of 19 live
Registered
49th of 57
by date
Lead sponsor
8 of 57
Assistance Publique - Hôpitaux de Paris

Among the 57 studies in Scoliosis with a site in France, this one is the 24th largest by planned enrollment of the 25 interventional ones that give a count, is one of 5 that started in 2025, is one of 24 with no phase, reaches primary completion later than 6 of the 19 other live ones, and was the 49th registered.

Scoliosis

660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.

Browse Scoliosis studies →

Open to participants now

18 of the 57 studies in Scoliosis with a site in France are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.

This study: 10 Years to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Scoliosis with a site in France, or all of them as a file.
02

Study summary

Scoliosis is a common three-dimensional spinal deformity defined by vertebral rotation.

Apart from collapse scoliosis, clinical and radiological similarities have been observed in children with secondary scoliosis of neuromuscular origin and children with idiopathic scoliosis in terms of the location and type of curvature.

It seems relevant to study the axial musculature in these children in more detail, particularly the deep muscles (transversospinales muscles) that have a stabilising and rotational function (multifidi and rotatores).

MRI is a non-invasive, non-irradiating technique used in the aetiological diagnosis of idiopathic scoliosis before adolescence and in the diagnosis of secondary scoliosis. However, the muscles are not specifically studied during these examinations. They are performed to analyse the spinal cord and rule out hinge deformities, although this technique does provide information on the paravertebral muscles.

The muscles of interest should be analysed using the usual sequences, with the addition of a sequence (DTI) specific to the study of deep muscles in children undergoing axial MRI. This adds 5 minutes to the standard MRI procedure.

Several morphological muscle parameters would be thus obtained on specific interest areas and then compared between right and left side and between two groups of children, 5 suffering from idiopathic scoliosis and 5 with neuromuscular scoliosis.

Idiopathic scoliosis corresponds to a heterogeneous group of patients in terms of the location, number and progression of the curves. The research hypothesis is that there may be a subgroup of patients with idiopathic scoliosis whose progression and/or aetiology is muscular in origin.

MRI could then become a routine examination in the assessment of all scoliosis, whether idiopathic or not.

Read the detailed description

This study is based on the hypothesis that there is a subgroup of patients with idiopathic scoliosis whose onset and/or progression is linked to muscle dysfunction.

This is a prospective, comparative, non-randomised study without a control group, performed in a single centre (Garches Hospital in France is a reference centre for neuromuscular diseases and disabilities). This research is in the field of data collection techniques using imaging methods on two populations of children with scoliosis.

OBJECTIVES The primary objective is the assessment of morphological differences in paravertebral muscles between children with scoliosis of different origins (idiopathic (IS) or neuromuscular (NMS))

Secondary objectives are:

  • Assessment of morphological differences between the paravertebral muscles of the convexity and concavity in idiopathic scoliosis
  • Assessment of morphological differences between the paravertebral muscles of the convexity and concavity in neuromuscular scoliosis; RESEARCH PROCESS

    1. Selection/Information The selection visit takes place during a routine consultation for the diagnosis/monitoring of scoliosis. Children with idiopathic or neuromuscular scoliosis who, as part of their treatment, need to undergo an axial MRI (spinal cord, pan spinal) and who meet the inclusion criteria could be enrolled.

      Children eligible for the study and their parents, if present, will be offered the opportunity to participate in this study by the investigating physician and will be given the study information sheet.

    2. Inclusion Inclusion is achieved after a minimum reflection period of 48 hours, and no later than the time of the MRI. After obtaining the child's consent and the signature of a parent or guardian, the child will be included in the study.

      They will undergo the MRI scan initially prescribed. If conditions allow, they will be asked to remain still for another 5 minutes while the additional sequence is performed.

      The CAPAS-Q questionnaire (2022 version) will be used to assess physical activity and sedentary behaviour and will be given to the child/adolescent by the investigator to complete. Help will be provided to younger children and children with reading difficulties. The questionnaire will be collected at the end of the visit after it has been completed by the patient.

    3. Data collection and analysis Imaging data will be pseudonymised, collected and analysed with Olea medical Software( olea-medical.com).

Three regions will be defined:

  • Region 1 corresponding to the proximal transitional vertebra
  • Region 2 corresponding to the apical vertebra (or disc)
  • Region 3 corresponding to the distal transitional vertebra These will then be divided into two zones according to the convexity and concavity of the curvature.
  • Region 1 convex / Region 1 concave
  • Region 2 convex / Region 2 concave
  • Region 3 convex / Region 3 concave

Thus, six regions will be defined and seven parameters per region established, i.e. 42 measurements per MRI:

  • Cross-sectional area
  • Pennation angle
  • Number of muscle fibres
  • T1 value
  • T2 value
  • Anisotropy fraction value
  • Diffusivity value (average, radial, axial)

Statistical analysis will be descriptive (prospective descriptive study). Quantitative variables will be described by the mean, standard deviation, median and interquartile range.

Qualitative variables will be described by the number of cases and frequency.

Comparisons will be made between the two groups of children with scoliosis according to the aetiology of the scoliosis.

For each of these parameters, non-parametric tests (Wilcoxon, Mann-Whitney) will be performed.

A p-value \< 0.05 will be considered significant. No significant difference will be sought between the two groups of children with scoliosis for each parameter, in order to verify the matching of the groups.

  • Age
  • Gender
  • BMI
  • CAPAS-Q score (activity and sedentary lifestyle)
  • Cobb angle value;
03

Conditions studied

  • Scoliosis
  • Scoliosis Idiopathic
  • Scoliosis Neuromuscular

Browse trials for

Keywords

  • scoliosis
  • MRI
  • Scoliosis Idiopathic
  • Scoliosis Neuromuscular
  • spine
  • Children
04

Who can participate

Ages eligible
10 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children and adolescents aged 10 to 17 years old,
  • Scoliosis (idiopathic or neuromuscular) that is not collapsing
  • Cobb angle \<40°
  • Female preferred
  • Patient able to walk
  • Average or low \<20kg/m2
  • Signature of by legal guardians
  • Affiliation with a social security scheme (beneficiary or dependent).

Exclusion criteria

Exclusion Criteria:

  • Refusal of the patient and/or parents to participate in the study
  • Inability to cooperate
  • Subject with a to MRI
  • History of spinal surgery
  • Not affiliated with a social security scheme (beneficiary or entitled person)
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Active comparator
    idiopathic scoliosis (IS)

    Procedure: Additional 5 minutes of lying down position during MRI

  • Active comparator
    neuromuscular scoliosis (NMS)

    Procedure: Additional 5 minutes of lying down position during MRI

Interventions

  • ProcedureAdditional 5 minutes of lying down position during MRI

    During axial MRI for scoliosis assessment, additional 5 minutes of lying down position in order to performing a specific sequence for the study of the vertebral muscles (Diffusion Tensor Imaging).

06

What researchers measure

Primary outcomes

  1. Muscular parameters defined in areas of specific interest and studied in the concavity and convexity of the main curvature: Cross-sectional area

    Analysis of differences in several morphological muscle parameters obtained from MRI scans between children with scoliosis (SI versus SNM). \- Cross-sectional area The parameter will be defined in areas of specific interest at the transitional vertebrae and apical vertebrae and will be studied in the concavity and convexity.

    Time frame: at baseline

  2. Muscular parameters defined in areas of specific interest and studied in the concavity and convexity of the main curvature: Pennation angle

    Analysis of differences in several morphological muscle parameters obtained from MRI scans between children with scoliosis (SI versus SNM). \- Pennation angle The parameter will be defined in areas of specific interest at the transitional vertebrae and apical vertebrae and will be studied in the concavity and convexity.

    Time frame: at baseline

  3. Muscular parameters defined in areas of specific interest and studied in the concavity and convexity of the main curvature: Number of muscle fibres

    Analysis of differences in several morphological muscle parameters obtained from MRI scans between children with scoliosis (SI versus SNM). \- Number of muscle fibres The parameter will be defined in areas of specific interest at the transitional vertebrae and apical vertebrae and will be studied in the concavity and convexity.

    Time frame: at baseline

  4. Muscular parameters defined in areas of specific interest and studied in the concavity and convexity of the main curvature: T1 value

    Analysis of differences in several morphological muscle parameters obtained from MRI scans between children with scoliosis (SI versus SNM). \- T1 value The parameter will be defined in areas of specific interest at the transitional vertebrae and apical vertebrae and will be studied in the concavity and convexity.

    Time frame: at baseline

  5. Muscular parameters defined in areas of specific interest and studied in the concavity and convexity of the main curvature: Anisotropy fraction value

    Analysis of differences in several morphological muscle parameters obtained from MRI scans between children with scoliosis (SI versus SNM). \- Anisotropy fraction value These parameters will be defined in areas of specific interest at the transitional vertebrae and apical vertebrae and will be studied in the concavity and convexity.

    Time frame: at baseline

  6. Muscular parameters defined in areas of specific interest and studied in the concavity and convexity of the main curvature: Diffusivity value

    Analysis of differences in several morphological muscle parameters obtained from MRI scans between children with scoliosis (SI versus SNM). \- Diffusivity value (average, radial, axial) These parameters will be defined in areas of specific interest at the transitional vertebrae and apical vertebrae and will be studied in the concavity and convexity.

    Time frame: at baseline

  7. Muscular parameters defined in areas of specific interest and studied in the concavity and convexity of the main curvature: T2 value

    Analysis of differences in several morphological muscle parameters obtained from MRI scans between children with scoliosis (SI versus SNM). \- T2 value These parameters will be defined in areas of specific interest at the transitional vertebrae and apical vertebrae and will be studied in the concavity and convexity.

    Time frame: at baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Aug 2027, 25 months after the start.

Of 224 non-industry interventional studies with no phase under Scoliosis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 58. This study's planned 25 months is above that.

Counting every sponsor, half of 234 studies reached it within 22 months; a quarter within 8 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 15, 2025
First posted
Aug 22, 2025
StartActual
Jul 17, 2025
Primary completionEst.
Aug 2027
CompletionEst.
Aug 2027
Last update
Aug 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07135765
Responsible party
Sponsor
First posted
Aug 22, 2025
Start date
Jul 17, 2025
Primary completion
Aug 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Aug 22, 2025

Study contacts

Hélène Gouz, MD
Contact
helene.gouze@aphp.fr
+33149094674
Marie-Line PISSONNIER, MD, PhD
Contact
ml.pissonnier@gmail.com
+33 671612829
Hélène Gouz, MD
principal investigator · CHU Raymond Poincaré - APHP
Robert Carlier, MD, PhD
study director · CHU Raymond Poincaré - APHP

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion